Fact CheckerSign in

NCT05607797Completed

Genetic of Chronic Kidney Disease and Gout in New Caledonia

Genetic of Chronic Kidney Disease and Gout : Analysis of Melanesian Families From New Caledonia

Source: ClinicalTrials.gov · Last updated 27 Nov 2024

Brief summary (registry, in English)

The goal of this research is to study the associations of genetic variants of gout and kidney failure, which are very common in the Melanesian population in New Caledonia

Status (registry)
Completed
Study type
Interventional
Enrollment
1858 (actual)
First submitted
18 Oct 2022
Start date
14 Mar 2023
Primary completion date
30 Apr 2024
Lead sponsor
Lille Catholic University
NCT number
NCT05607797

What you commit to

  • Study type: Interventional
  • Participants enrolled: 1858
  • From 14 Mar 2023 to the primary completion date, 30 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Pregnant women
  • Individuals under guardianship / curatorship / judicially incapacitated

Who the study is looking for

  • Criteria common to the 3 cohorts :
  • \- Consenting to participate in the study and having signed the informed consent
  • \- Claiming to be of Melanesian ethnicity
  • Patients with gout :
    • Age: 18 - 70 years old
    • To be included in the study, a patient with a diagnosis of gout in his medical file or declaring to have gout will have to satisfy to the ACR/EULAR (ref) classification criteria :
    • have had at least one episode of swelling, pain spontaneous, or triggered by pressure, of a joint peripheral or a bursa AND evidence of sodium urate crystals in a joint or bursitis symptomatic or by puncture of a tophus reported in his medical file.
    • Or Score \> or =8 according to ACR/EULAR clinical criteria
  • Patients with CKD
    • Age: 18 - 70 years old
    • Patients on dialysis or CKD clinically diagnosed on the basis of:
    • Markers of kidney damage (one or more) : Albuminuria (ACR ≥ 30 mg/g), Urinary sediment abnormalities (e.g., casts urinary), Electrolyte abnormalities and other, abnormalities due to tubular disorders (eg, hyperkalemia), abnormalities detected by histology, structural abnormalities detected by imaging (e.g.,USG), history of kidney transplantation
    • Decreased kidney function: GFR \< 60 ml/min/1.73 m² (calculated according to the Chronic Kidney Disease - EPIdemiology formula: CKD-EPI)
  • Controls cohort
    • Absence of gout or CKD
    • Age: 30 - 80 years old

Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Medical Center of Wé (Lifou Island)
Coordinator of this site? Confirm its status
NoumeaNew CaledoniaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.